Ngoc Bao Thi Nguyen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4400 Grant Blvd Ste 103, Yukon, OK 73099 Phone: 405-467-5340 Fax: 405-467-5341 |
Henry Le, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 S Mustang Rd, Yukon, OK 73099 Phone: 405-936-5910 Fax: 405-577-2605 |
Dena Moreman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Wimberly Dr, Yukon, OK 73099 Phone: 405-570-1188 Fax: 405-265-3337 |
Alicia Claire Hubbell, MD, MBA Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Integris Canadian Valley Hospital, 1201 Health Center Parkway, Yukon, OK 73099 Phone: 817-996-1725 |
Glen Dewayne Hyde, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12200 Ashford Dr, Yukon, OK 73099 Phone: 405-283-9000 Fax: 405-283-9025 |
Mr. Farhan Mujtaba Qureshi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Health Center Parkway, Suite 200, Yukon, OK 73099 Phone: 405-717-6952 Fax: 405-350-9687 |
News Archive
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today introduced the Microcyn Negative-Pressure Wound Therapy Solution™ for the U.S. professional healthcare market. Within the pH ranges of 6-7.8 desired for optimum negative-pressure wound therapy, Microcyn is intended for the irrigation and management of wounds via these advanced systems.
The Prostate Cancer Foundation (PCF) has announced that more than 200 new therapies are being developed for prostate cancer, many by researchers supported by the PCF. Substantially more prostate cancer therapies are in later stages of clinical development (Phases II and III) than ever before.
More than 1 in 20 (nearly 3.3 million) children between the ages of 3 and 17 have a dizziness or balance problem, according to an analysis of the first large-scale, nationally representative survey of these problems in U.S. children.
Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new treatment option, the Abbott Absorb stent, which literally disappears in the body over time.
A high level of a hormone that regulates phosphate is associated with an increased risk of kidney failure and death among chronic kidney disease (CKD) patients, according to a recent study led by researchers at the University of Miami and funded by the National Institute of Diabetes and Digestive Diseases and Kidney Diseases (NIDDK) at the National Institutes of Health.
› Verified 4 days ago